MedTrace Logo

Symptom Tracking in Assisted Reproductive Technologies

NCT01746797 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2018-01-18

No results posted yet for this study

Summary

This study assesses risk factors for depressive relapse in women undergoing fertility treatment with histories of major depressive disorder (MDD) or bipolar disorder. The study is focused on the acute risk factors of depressive relapse.

The investigators hypothesize that risk for depressive relapse will be greater among women who stop antidepressants compared to those who continue treatment with these agents.

Conditions

  • Depression Relapse in Women Undergoing Fertility Treatment

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Marlene F Freeman, MD · Massachusetts General Hospital

  • Lee S Cohen, MD · Massachusetts General Hospital

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2016-06-30
Completion
2018-01-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01746797 on ClinicalTrials.gov